Predictors of Survival in Favorable Risk Patients with Metastatic Renal Cell Carcinoma Treated with a Single-Agent First-Line Therapy.

Ryuichi Mizuno,Kimiharu Takamatsu,Yota Yasumizu,Nobuyuki Tanaka,Toshikazu Takeda,Shinya Morita,Kazuhiro Matsumoto,Takeo Kosaka,Hiroshi Asanuma,Shuji Mikami,Mototsugu Oya

Urologia internationalis（2022）

引用 1|浏览8

暂无评分

摘要

First-line systemic therapy for favorable risk mRCC patients with a single agent resulted in relatively longer PFS and OS. A longer duration of first-line treatment and lung only metastases are correlated with longer OS.

查看译文

关键词

Favorable risk,International metastatic renal cell carcinoma database consortium,Kidney cancer

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要